Quest Diagnostics (DGX) FY2024 results: revenue $9.9 billion, up 6.7% on the year
Quest Diagnostics Inc. (DGX) reported revenue of $9.9 billion for fiscal 2024, the year ended 31 December 2024, up 6.7% on the year before. Net income was $871 million, up 2.0%, and diluted earnings per share $7.69. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2025.
Revenue
$9.9 billion
+6.7% on the year
FY2017FY2024
Operating margin
13.6%
13.6% a year earlier
FY2017FY2024
Net income
$871 million
+2.0% on the year
FY2017FY2024
Diluted EPS
$7.69
+2.7% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
1,334
1,272
1,718
+4.9%
Capital expenditure
425
408
404
+4.2%
Free cash flow
909
864
1,314
+5.2%
Free cash flow margin
9.2%
9.3%
13.3%
Cash from investing
-2,548
-1,061
-543
Cash from financing
1,084
160
-1,732
+577.5%
Depreciation and amortisation
493
439
437
+12.3%
Share-based compensation
88.0
77.0
77.0
+14.3%
Buybacks
151
275
1,408
-45.1%
Dividends paid
331
314
305
+5.4%
Diluted shares, weighted
113m
113m
118m
0.0%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
6,778
6,307
5,893
+7.5%
Non-controlling interest
35.0
35.0
37.0
0.0%
Redeemable equity
83.0
76.0
77.0
+9.2%
Debt
6,217
4,713
3,980
+31.9%
Operating lease liabilities
535
503
489
+6.4%
Finance lease liabilities
16.0
6.0
7.0
+166.7%
Other liabilities
2,489
2,382
2,354
+4.5%
Total liabilities and equity
16,153
14,022
12,837
+15.2%
Fixed assets
2,113
1,816
1,766
+16.4%
Goodwill
8,856
7,733
7,220
+14.5%
Intangible assets
1,763
1,166
1,092
+51.2%
Securities held for sale or to maturity
0.0
2.0
2.0
Cash and equivalents
549
686
315
-20.0%
Receivables
1,304
1,210
1,195
+7.8%
Inventory
188
190
192
-1.1%
Other assets
1,380
1,219
1,055
+13.2%
Total assets
16,153
14,022
12,837
+15.2%
10-K for the year ended 31 December 2024, filed 20 February 2025: the filing.